In the current study, we show that KU-0060648, a recently-developed water-soluble DNA-PKcs inhibitor [12, 19, 20], exerts potent anti-tumor activity in preclinical HCC models. The gene discussed is PRKDC; the disease is hepatocellular carcinoma.